nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—PTGS2—melanoma	0.208	0.365	CbGaD
Salicylic acid—ALB—melanoma	0.185	0.325	CbGaD
Salicylic acid—ABCB1—melanoma	0.177	0.31	CbGaD
Salicylic acid—ALB—Vemurafenib—melanoma	0.0918	0.404	CbGbCtD
Salicylic acid—SLC22A7—Docetaxel—melanoma	0.087	0.383	CbGbCtD
Salicylic acid—ABCB1—Dactinomycin—melanoma	0.0319	0.14	CbGbCtD
Salicylic acid—ABCB1—Docetaxel—melanoma	0.0165	0.0725	CbGbCtD
Salicylic acid—Skin papilloma—Vemurafenib—melanoma	0.00796	0.0983	CcSEcCtD
Salicylic acid—Localized exfoliation—Bleomycin—melanoma	0.00584	0.072	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—HSPA5—melanoma	0.00246	0.332	CrCbGaD
Salicylic acid—SLC22A8—optic choroid—melanoma	0.00211	0.172	CbGeAlD
Salicylic acid—Burning sensation—Carmustine—melanoma	0.00198	0.0244	CcSEcCtD
Salicylic acid—Duodenal ulcer—Docetaxel—melanoma	0.00183	0.0225	CcSEcCtD
Salicylic acid—Skin exfoliation—Bleomycin—melanoma	0.0015	0.0185	CcSEcCtD
Salicylic acid—Hearing impaired—Temozolomide—melanoma	0.00139	0.0172	CcSEcCtD
Salicylic acid—Oesophagitis—Dactinomycin—melanoma	0.00134	0.0165	CcSEcCtD
Salicylic acid—Skin exfoliation—Carmustine—melanoma	0.00131	0.0162	CcSEcCtD
Salicylic acid—Heartburn—Docetaxel—melanoma	0.00128	0.0158	CcSEcCtD
Salicylic acid—Burning sensation—Docetaxel—melanoma	0.00127	0.0157	CcSEcCtD
Salicylic acid—Skin exfoliation—Temozolomide—melanoma	0.00127	0.0156	CcSEcCtD
Salicylic acid—Erythema multiforme—Vemurafenib—melanoma	0.00123	0.0152	CcSEcCtD
Salicylic acid—Erythema—Vemurafenib—melanoma	0.00113	0.014	CcSEcCtD
Salicylic acid—Dysgeusia—Vemurafenib—melanoma	0.00111	0.0137	CcSEcCtD
Salicylic acid—Lethargy—Dactinomycin—melanoma	0.00109	0.0134	CcSEcCtD
Salicylic acid—Deafness—Temozolomide—melanoma	0.00108	0.0133	CcSEcCtD
Salicylic acid—PTGS2—leg—melanoma	0.00106	0.0863	CbGeAlD
Salicylic acid—Acetylsalicylic acid—TP53—melanoma	0.00101	0.137	CrCbGaD
Salicylic acid—PTGS2—hindlimb—melanoma	0.000949	0.0771	CbGeAlD
Salicylic acid—Hearing impaired—Docetaxel—melanoma	0.000927	0.0114	CcSEcCtD
Salicylic acid—Skin exfoliation—Docetaxel—melanoma	0.000842	0.0104	CcSEcCtD
Salicylic acid—PTGS2—appendage—melanoma	0.000814	0.0661	CbGeAlD
Salicylic acid—Oesophagitis—Docetaxel—melanoma	0.000806	0.00994	CcSEcCtD
Salicylic acid—Decreased appetite—Vemurafenib—melanoma	0.000805	0.00993	CcSEcCtD
Salicylic acid—Constipation—Vemurafenib—melanoma	0.000792	0.00977	CcSEcCtD
Salicylic acid—Lightheadedness—Docetaxel—melanoma	0.000789	0.00974	CcSEcCtD
Salicylic acid—Weight increased—Temozolomide—melanoma	0.000757	0.00934	CcSEcCtD
Salicylic acid—Hepatitis—Dactinomycin—melanoma	0.000737	0.00909	CcSEcCtD
Salicylic acid—Deafness—Docetaxel—melanoma	0.000716	0.00883	CcSEcCtD
Salicylic acid—Erythema multiforme—Dactinomycin—melanoma	0.000696	0.00859	CcSEcCtD
Salicylic acid—Erythema—Bleomycin—melanoma	0.000687	0.00848	CcSEcCtD
Salicylic acid—Hallucination—Carmustine—melanoma	0.000686	0.00846	CcSEcCtD
Salicylic acid—PTGS2—skin epidermis—melanoma	0.000677	0.055	CbGeAlD
Salicylic acid—Hepatitis—Temozolomide—melanoma	0.000666	0.00822	CcSEcCtD
Salicylic acid—Hallucination—Temozolomide—melanoma	0.000663	0.00818	CcSEcCtD
Salicylic acid—Pruritus—Vemurafenib—melanoma	0.000655	0.00808	CcSEcCtD
Salicylic acid—Lethargy—Docetaxel—melanoma	0.000653	0.00806	CcSEcCtD
Salicylic acid—Erythema—Dactinomycin—melanoma	0.000641	0.00791	CcSEcCtD
Salicylic acid—Diarrhoea—Vemurafenib—melanoma	0.000634	0.00782	CcSEcCtD
Salicylic acid—Erythema multiforme—Temozolomide—melanoma	0.00063	0.00777	CcSEcCtD
Salicylic acid—Tinnitus—Temozolomide—melanoma	0.000621	0.00766	CcSEcCtD
Salicylic acid—Dizziness—Vemurafenib—melanoma	0.000612	0.00755	CcSEcCtD
Salicylic acid—Erythema—Carmustine—melanoma	0.0006	0.0074	CcSEcCtD
Salicylic acid—Vomiting—Vemurafenib—melanoma	0.000589	0.00726	CcSEcCtD
Salicylic acid—Abdominal pain upper—Docetaxel—melanoma	0.000585	0.00722	CcSEcCtD
Salicylic acid—Rash—Vemurafenib—melanoma	0.000584	0.0072	CcSEcCtD
Salicylic acid—Dermatitis—Vemurafenib—melanoma	0.000583	0.0072	CcSEcCtD
Salicylic acid—Headache—Vemurafenib—melanoma	0.00058	0.00716	CcSEcCtD
Salicylic acid—Erythema—Temozolomide—melanoma	0.00058	0.00715	CcSEcCtD
Salicylic acid—Dysgeusia—Temozolomide—melanoma	0.000568	0.00701	CcSEcCtD
Salicylic acid—Confusional state—Bleomycin—melanoma	0.000566	0.00698	CcSEcCtD
Salicylic acid—SLC16A1—eye—melanoma	0.000563	0.0457	CbGeAlD
Salicylic acid—Oedema—Bleomycin—melanoma	0.000561	0.00692	CcSEcCtD
Salicylic acid—SLC16A1—retina—melanoma	0.000558	0.0453	CbGeAlD
Salicylic acid—Nausea—Vemurafenib—melanoma	0.00055	0.00679	CcSEcCtD
Salicylic acid—Mesalazine—PPARG—melanoma	0.000544	0.0735	CrCbGaD
Salicylic acid—Anorexia—Bleomycin—melanoma	0.000535	0.0066	CcSEcCtD
Salicylic acid—Oedema—Dactinomycin—melanoma	0.000523	0.00646	CcSEcCtD
Salicylic acid—PTGS1—endothelium—melanoma	0.000514	0.0417	CbGeAlD
Salicylic acid—Weight increased—Docetaxel—melanoma	0.000504	0.00621	CcSEcCtD
Salicylic acid—Anorexia—Dactinomycin—melanoma	0.000499	0.00615	CcSEcCtD
Salicylic acid—Confusional state—Carmustine—melanoma	0.000494	0.00609	CcSEcCtD
Salicylic acid—PTGS2—endothelium—melanoma	0.000492	0.0399	CbGeAlD
Salicylic acid—Oedema—Carmustine—melanoma	0.00049	0.00604	CcSEcCtD
Salicylic acid—Decreased appetite—Bleomycin—melanoma	0.000488	0.00602	CcSEcCtD
Salicylic acid—Pain—Bleomycin—melanoma	0.00048	0.00592	CcSEcCtD
Salicylic acid—Confusional state—Temozolomide—melanoma	0.000477	0.00589	CcSEcCtD
Salicylic acid—PTGS1—blood vessel—melanoma	0.000474	0.0385	CbGeAlD
Salicylic acid—Oedema—Temozolomide—melanoma	0.000473	0.00584	CcSEcCtD
Salicylic acid—Anorexia—Carmustine—melanoma	0.000467	0.00576	CcSEcCtD
Salicylic acid—Epistaxis—Docetaxel—melanoma	0.000465	0.00574	CcSEcCtD
Salicylic acid—Feeling abnormal—Bleomycin—melanoma	0.000462	0.0057	CcSEcCtD
Salicylic acid—Decreased appetite—Dactinomycin—melanoma	0.000455	0.00561	CcSEcCtD
Salicylic acid—Salicylate-sodium—PTGS2—melanoma	0.000454	0.0614	CrCbGaD
Salicylic acid—PTGS2—blood vessel—melanoma	0.000453	0.0368	CbGeAlD
Salicylic acid—Anorexia—Temozolomide—melanoma	0.000451	0.00557	CcSEcCtD
Salicylic acid—Pain—Dactinomycin—melanoma	0.000447	0.00552	CcSEcCtD
Salicylic acid—Urticaria—Bleomycin—melanoma	0.000446	0.0055	CcSEcCtD
Salicylic acid—Hepatitis—Docetaxel—melanoma	0.000443	0.00547	CcSEcCtD
Salicylic acid—Somnolence—Carmustine—melanoma	0.000435	0.00537	CcSEcCtD
Salicylic acid—Feeling abnormal—Dactinomycin—melanoma	0.000431	0.00532	CcSEcCtD
Salicylic acid—Decreased appetite—Carmustine—melanoma	0.000426	0.00525	CcSEcCtD
Salicylic acid—SLC22A8—eye—melanoma	0.000425	0.0345	CbGeAlD
Salicylic acid—Somnolence—Temozolomide—melanoma	0.000421	0.00519	CcSEcCtD
Salicylic acid—Erythema multiforme—Docetaxel—melanoma	0.000419	0.00517	CcSEcCtD
Salicylic acid—Pain—Carmustine—melanoma	0.000419	0.00517	CcSEcCtD
Salicylic acid—Constipation—Carmustine—melanoma	0.000419	0.00517	CcSEcCtD
Salicylic acid—Dyspepsia—Temozolomide—melanoma	0.000417	0.00514	CcSEcCtD
Salicylic acid—Decreased appetite—Temozolomide—melanoma	0.000411	0.00508	CcSEcCtD
Salicylic acid—Pain—Temozolomide—melanoma	0.000405	0.00499	CcSEcCtD
Salicylic acid—Constipation—Temozolomide—melanoma	0.000405	0.00499	CcSEcCtD
Salicylic acid—Feeling abnormal—Carmustine—melanoma	0.000404	0.00498	CcSEcCtD
Salicylic acid—Pruritus—Bleomycin—melanoma	0.000397	0.0049	CcSEcCtD
Salicylic acid—Feeling abnormal—Temozolomide—melanoma	0.00039	0.00481	CcSEcCtD
Salicylic acid—Erythema—Docetaxel—melanoma	0.000386	0.00476	CcSEcCtD
Salicylic acid—Dysgeusia—Docetaxel—melanoma	0.000378	0.00466	CcSEcCtD
Salicylic acid—Urticaria—Temozolomide—melanoma	0.000376	0.00464	CcSEcCtD
Salicylic acid—Diarrhoea—Dactinomycin—melanoma	0.000358	0.00442	CcSEcCtD
Salicylic acid—Vomiting—Bleomycin—melanoma	0.000357	0.0044	CcSEcCtD
Salicylic acid—Rash—Bleomycin—melanoma	0.000354	0.00436	CcSEcCtD
Salicylic acid—Dermatitis—Bleomycin—melanoma	0.000353	0.00436	CcSEcCtD
Salicylic acid—Diarrhoea—Carmustine—melanoma	0.000335	0.00413	CcSEcCtD
Salicylic acid—Pruritus—Temozolomide—melanoma	0.000335	0.00413	CcSEcCtD
Salicylic acid—Nausea—Bleomycin—melanoma	0.000333	0.00411	CcSEcCtD
Salicylic acid—Vomiting—Dactinomycin—melanoma	0.000333	0.0041	CcSEcCtD
Salicylic acid—Rash—Dactinomycin—melanoma	0.00033	0.00407	CcSEcCtD
Salicylic acid—Dizziness—Carmustine—melanoma	0.000324	0.004	CcSEcCtD
Salicylic acid—Diarrhoea—Temozolomide—melanoma	0.000324	0.00399	CcSEcCtD
Salicylic acid—SLC16A1—head—melanoma	0.000319	0.0259	CbGeAlD
Salicylic acid—Confusional state—Docetaxel—melanoma	0.000317	0.00392	CcSEcCtD
Salicylic acid—Oedema—Docetaxel—melanoma	0.000315	0.00388	CcSEcCtD
Salicylic acid—Dizziness—Temozolomide—melanoma	0.000313	0.00386	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS2—melanoma	0.000311	0.0421	CrCbGaD
Salicylic acid—Vomiting—Carmustine—melanoma	0.000311	0.00384	CcSEcCtD
Salicylic acid—Nausea—Dactinomycin—melanoma	0.000311	0.00383	CcSEcCtD
Salicylic acid—Rash—Carmustine—melanoma	0.000309	0.00381	CcSEcCtD
Salicylic acid—Dermatitis—Carmustine—melanoma	0.000309	0.00381	CcSEcCtD
Salicylic acid—Headache—Carmustine—melanoma	0.000307	0.00379	CcSEcCtD
Salicylic acid—Vomiting—Temozolomide—melanoma	0.000301	0.00371	CcSEcCtD
Salicylic acid—Anorexia—Docetaxel—melanoma	0.0003	0.0037	CcSEcCtD
Salicylic acid—Rash—Temozolomide—melanoma	0.000298	0.00368	CcSEcCtD
Salicylic acid—Dermatitis—Temozolomide—melanoma	0.000298	0.00368	CcSEcCtD
Salicylic acid—Headache—Temozolomide—melanoma	0.000296	0.00366	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—PTGS2—melanoma	0.000293	0.0396	CrCbGaD
Salicylic acid—Diflunisal—PTGS2—melanoma	0.000293	0.0396	CrCbGaD
Salicylic acid—Nausea—Carmustine—melanoma	0.000291	0.00359	CcSEcCtD
Salicylic acid—Nausea—Temozolomide—melanoma	0.000281	0.00347	CcSEcCtD
Salicylic acid—ABCB1—blood vessel—melanoma	0.00028	0.0228	CbGeAlD
Salicylic acid—Somnolence—Docetaxel—melanoma	0.00028	0.00345	CcSEcCtD
Salicylic acid—Magnesium salicylate—ALB—melanoma	0.000277	0.0375	CrCbGaD
Salicylic acid—Dyspepsia—Docetaxel—melanoma	0.000277	0.00342	CcSEcCtD
Salicylic acid—SLCO2B1—head—melanoma	0.000275	0.0223	CbGeAlD
Salicylic acid—Decreased appetite—Docetaxel—melanoma	0.000274	0.00338	CcSEcCtD
Salicylic acid—Pain—Docetaxel—melanoma	0.000269	0.00332	CcSEcCtD
Salicylic acid—Constipation—Docetaxel—melanoma	0.000269	0.00332	CcSEcCtD
Salicylic acid—Salsalate—PTGS2—melanoma	0.000265	0.0358	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS2—melanoma	0.000261	0.0353	CrCbGaD
Salicylic acid—Diflunisal—ALB—melanoma	0.000261	0.0352	CrCbGaD
Salicylic acid—Feeling abnormal—Docetaxel—melanoma	0.000259	0.0032	CcSEcCtD
Salicylic acid—SLC22A8—head—melanoma	0.000241	0.0196	CbGeAlD
Salicylic acid—Mesalazine—PTGS2—melanoma	0.00023	0.031	CrCbGaD
Salicylic acid—SLC16A1—lymph node—melanoma	0.000224	0.0182	CbGeAlD
Salicylic acid—Pruritus—Docetaxel—melanoma	0.000223	0.00275	CcSEcCtD
Salicylic acid—PTGS1—skin of body—melanoma	0.00022	0.0178	CbGeAlD
Salicylic acid—Diarrhoea—Docetaxel—melanoma	0.000215	0.00266	CcSEcCtD
Salicylic acid—PTGS2—skin of body—melanoma	0.00021	0.017	CbGeAlD
Salicylic acid—Dizziness—Docetaxel—melanoma	0.000208	0.00257	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS2—melanoma	0.000203	0.0274	CrCbGaD
Salicylic acid—PTGS1—mammalian vulva—melanoma	0.0002	0.0163	CbGeAlD
Salicylic acid—Vomiting—Docetaxel—melanoma	0.0002	0.00247	CcSEcCtD
Salicylic acid—Rash—Docetaxel—melanoma	0.000198	0.00245	CcSEcCtD
Salicylic acid—Dermatitis—Docetaxel—melanoma	0.000198	0.00245	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS2—melanoma	0.000198	0.0267	CrCbGaD
Salicylic acid—Headache—Docetaxel—melanoma	0.000197	0.00243	CcSEcCtD
Salicylic acid—SLCO2B1—lymph node—melanoma	0.000192	0.0156	CbGeAlD
Salicylic acid—Nausea—Docetaxel—melanoma	0.000187	0.00231	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ALB—melanoma	0.000176	0.0238	CrCbGaD
Salicylic acid—ALB—lymph node—melanoma	0.000176	0.0143	CbGeAlD
Salicylic acid—Acetylsalicylic acid—ABCB1—melanoma	0.000168	0.0227	CrCbGaD
Salicylic acid—ABCB1—retina—melanoma	0.000148	0.012	CbGeAlD
Salicylic acid—PTGS1—head—melanoma	0.000143	0.0116	CbGeAlD
Salicylic acid—PTGS2—head—melanoma	0.000137	0.0111	CbGeAlD
Salicylic acid—ABCB1—mammalian vulva—melanoma	0.000118	0.00961	CbGeAlD
Salicylic acid—PTGS1—lymph node—melanoma	0.0001	0.00814	CbGeAlD
Salicylic acid—PTGS2—lymph node—melanoma	9.59e-05	0.00778	CbGeAlD
Salicylic acid—ABCB1—head—melanoma	8.47e-05	0.00688	CbGeAlD
Salicylic acid—ABCB1—lymph node—melanoma	5.93e-05	0.00482	CbGeAlD
Salicylic acid—PTGS1—Metabolism—GNA11—melanoma	1.65e-05	0.000161	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—VCAN—melanoma	1.64e-05	0.00016	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NFKB1—melanoma	1.64e-05	0.00016	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAC1—melanoma	1.63e-05	0.00016	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CUBN—melanoma	1.63e-05	0.000159	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—FASN—melanoma	1.61e-05	0.000157	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.6e-05	0.000156	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PPARG—melanoma	1.6e-05	0.000156	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SLC5A5—melanoma	1.58e-05	0.000155	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MMP1—melanoma	1.58e-05	0.000154	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LUM—melanoma	1.58e-05	0.000154	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PHGDH—melanoma	1.58e-05	0.000154	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.58e-05	0.000154	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CSPG4—melanoma	1.57e-05	0.000154	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BSG—melanoma	1.57e-05	0.000154	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SDHD—melanoma	1.57e-05	0.000154	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—AKT1—melanoma	1.56e-05	0.000152	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GAB2—melanoma	1.56e-05	0.000152	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.55e-05	0.000152	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CDK2—melanoma	1.55e-05	0.000151	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HPSE—melanoma	1.55e-05	0.000151	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HRAS—melanoma	1.53e-05	0.00015	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GNAQ—melanoma	1.53e-05	0.00015	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CD44—melanoma	1.53e-05	0.00015	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FASN—melanoma	1.53e-05	0.000149	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPAM—melanoma	1.52e-05	0.000149	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CUBN—melanoma	1.52e-05	0.000149	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.51e-05	0.000148	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.5e-05	0.000146	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.5e-05	0.000146	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.49e-05	0.000146	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—melanoma	1.49e-05	0.000145	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.48e-05	0.000145	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PLA2G6—melanoma	1.48e-05	0.000144	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—melanoma	1.47e-05	0.000144	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NRAS—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CSPG4—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SDHD—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BSG—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP1B1—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HDAC2—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FOXO4—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CXCR4—melanoma	1.47e-05	0.000143	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CD—melanoma	1.46e-05	0.000142	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD44—melanoma	1.45e-05	0.000142	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.45e-05	0.000142	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—FN1—melanoma	1.44e-05	0.000141	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.44e-05	0.000141	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ALB—melanoma	1.44e-05	0.000141	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NOS2—melanoma	1.42e-05	0.000139	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPAM—melanoma	1.42e-05	0.000139	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.42e-05	0.000139	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.42e-05	0.000139	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.42e-05	0.000139	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK3—melanoma	1.41e-05	0.000137	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CA—melanoma	1.39e-05	0.000136	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP17A1—melanoma	1.38e-05	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CG—melanoma	1.38e-05	0.000135	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—melanoma	1.37e-05	0.000134	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.36e-05	0.000133	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—EGF—melanoma	1.36e-05	0.000133	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—AKT1—melanoma	1.35e-05	0.000132	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.35e-05	0.000132	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.35e-05	0.000132	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.34e-05	0.000131	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT3—melanoma	1.34e-05	0.000131	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK1—melanoma	1.34e-05	0.000131	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—melanoma	1.34e-05	0.000131	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—VCAN—melanoma	1.33e-05	0.00013	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GNA11—melanoma	1.31e-05	0.000128	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.29e-05	0.000126	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PLA2G6—melanoma	1.29e-05	0.000126	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—FASN—melanoma	1.28e-05	0.000125	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CB—melanoma	1.27e-05	0.000124	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—melanoma	1.26e-05	0.000123	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IGF1—melanoma	1.26e-05	0.000123	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—melanoma	1.26e-05	0.000123	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SLC5A5—melanoma	1.26e-05	0.000123	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.26e-05	0.000123	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.25e-05	0.000122	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.23e-05	0.00012	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GNAQ—melanoma	1.21e-05	0.000119	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CD44—melanoma	1.21e-05	0.000119	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CD—melanoma	1.21e-05	0.000118	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.21e-05	0.000118	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PLA2G6—melanoma	1.21e-05	0.000118	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ABCB1—melanoma	1.21e-05	0.000118	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.19e-05	0.000116	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.19e-05	0.000116	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB4—melanoma	1.18e-05	0.000116	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN2B—melanoma	1.17e-05	0.000115	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP1B1—melanoma	1.16e-05	0.000114	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—VCAN—melanoma	1.16e-05	0.000114	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—melanoma	1.16e-05	0.000113	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AKT1—melanoma	1.13e-05	0.000111	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD86—melanoma	1.13e-05	0.000111	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—melanoma	1.12e-05	0.00011	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP17A1—melanoma	1.12e-05	0.000109	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PRKCA—melanoma	1.11e-05	0.000109	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.1e-05	0.000108	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ERCC2—melanoma	1.1e-05	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGF1—melanoma	1.1e-05	0.000107	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTEN—melanoma	1.1e-05	0.000107	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—VCAN—melanoma	1.09e-05	0.000106	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HRAS—melanoma	1.07e-05	0.000105	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PDGFRA—melanoma	1.06e-05	0.000104	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GNA11—melanoma	1.06e-05	0.000103	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CB—melanoma	1.06e-05	0.000103	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PRKCA—melanoma	1.05e-05	0.000103	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERCC2—melanoma	1.05e-05	0.000102	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—FASN—melanoma	1.03e-05	0.000101	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAP2K2—melanoma	1.03e-05	0.000101	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—melanoma	1.03e-05	0.0001	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.03e-05	0.0001	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.03e-05	0.0001	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.02e-05	9.98e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC5A5—melanoma	1.02e-05	9.94e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.01e-05	9.82e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.92e-06	9.69e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CD44—melanoma	9.83e-06	9.6e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GNAQ—melanoma	9.83e-06	9.6e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP17A1—melanoma	9.81e-06	9.58e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HLA-A—melanoma	9.8e-06	9.57e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TERT—melanoma	9.8e-06	9.57e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAC1—melanoma	9.77e-06	9.55e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—melanoma	9.71e-06	9.48e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.62e-06	9.4e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ABCB1—melanoma	9.59e-06	9.37e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.53e-06	9.32e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AKT1—melanoma	9.48e-06	9.27e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP1B1—melanoma	9.42e-06	9.21e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HIF1A—melanoma	9.37e-06	9.15e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GNA11—melanoma	9.26e-06	9.05e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP17A1—melanoma	9.16e-06	8.95e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.13e-06	8.92e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.08e-06	8.87e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—FASN—melanoma	9.06e-06	8.86e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.04e-06	8.83e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.92e-06	8.72e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC5A5—melanoma	8.91e-06	8.71e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PRKCA—melanoma	8.82e-06	8.62e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ERCC2—melanoma	8.75e-06	8.55e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—melanoma	8.71e-06	8.51e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GNA11—melanoma	8.65e-06	8.45e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GNAQ—melanoma	8.61e-06	8.41e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CD44—melanoma	8.61e-06	8.41e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOS2—melanoma	8.52e-06	8.33e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FASN—melanoma	8.47e-06	8.27e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOTCH1—melanoma	8.44e-06	8.25e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARG—melanoma	8.4e-06	8.21e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC5A5—melanoma	8.33e-06	8.14e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.31e-06	8.12e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD80—melanoma	8.27e-06	8.08e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP1B1—melanoma	8.25e-06	8.07e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—melanoma	8.25e-06	8.07e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KIT—melanoma	8.25e-06	8.07e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—melanoma	8.25e-06	8.06e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGF—melanoma	8.16e-06	7.97e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NRAS—melanoma	8.15e-06	7.96e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CD44—melanoma	8.04e-06	7.86e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GNAQ—melanoma	8.04e-06	7.86e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.88e-06	7.7e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.8e-06	7.63e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK3—melanoma	7.8e-06	7.63e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BRAF—melanoma	7.76e-06	7.58e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCB1—melanoma	7.76e-06	7.58e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—melanoma	7.74e-06	7.57e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP1B1—melanoma	7.71e-06	7.54e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CD—melanoma	7.65e-06	7.48e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALB—melanoma	7.56e-06	7.38e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK1—melanoma	7.42e-06	7.26e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAP2K1—melanoma	7.3e-06	7.14e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CD—melanoma	7.26e-06	7.09e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.25e-06	7.08e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PRKCA—melanoma	7.14e-06	6.98e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ERCC2—melanoma	7.08e-06	6.92e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—melanoma	7.01e-06	6.85e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGF2—melanoma	6.95e-06	6.79e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—melanoma	6.91e-06	6.75e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.81e-06	6.65e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CB—melanoma	6.67e-06	6.52e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARG—melanoma	6.67e-06	6.52e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—melanoma	6.61e-06	6.46e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MDM2—melanoma	6.5e-06	6.35e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—melanoma	6.44e-06	6.3e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—melanoma	6.41e-06	6.26e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCB1—melanoma	6.35e-06	6.21e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AKT1—melanoma	6.32e-06	6.18e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CB—melanoma	6.32e-06	6.18e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD4—melanoma	6.31e-06	6.17e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PRKCA—melanoma	6.26e-06	6.11e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—melanoma	6.23e-06	6.09e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ERCC2—melanoma	6.2e-06	6.06e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CD—melanoma	6.08e-06	5.94e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALB—melanoma	6e-06	5.86e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—HRAS—melanoma	5.96e-06	5.82e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1B—melanoma	5.93e-06	5.8e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.87e-06	5.73e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PRKCA—melanoma	5.84e-06	5.71e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ERCC2—melanoma	5.8e-06	5.66e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTEN—melanoma	5.76e-06	5.63e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CTNNB1—melanoma	5.61e-06	5.48e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—melanoma	5.59e-06	5.46e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1A—melanoma	5.48e-06	5.35e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTEN—melanoma	5.46e-06	5.34e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARG—melanoma	5.4e-06	5.27e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CB—melanoma	5.3e-06	5.18e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT1—melanoma	5.26e-06	5.14e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CD—melanoma	4.92e-06	4.8e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—melanoma	4.9e-06	4.79e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—melanoma	4.89e-06	4.78e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NRAS—melanoma	4.88e-06	4.76e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.8e-06	4.69e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARG—melanoma	4.73e-06	4.62e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK3—melanoma	4.67e-06	4.56e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—melanoma	4.58e-06	4.47e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTEN—melanoma	4.58e-06	4.47e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—melanoma	4.54e-06	4.44e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK1—melanoma	4.44e-06	4.34e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—melanoma	4.44e-06	4.34e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARG—melanoma	4.42e-06	4.32e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CD—melanoma	4.31e-06	4.21e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CB—melanoma	4.28e-06	4.19e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALB—melanoma	4.25e-06	4.16e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—melanoma	4.25e-06	4.15e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—melanoma	4.2e-06	4.1e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—melanoma	4.07e-06	3.97e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CD—melanoma	4.02e-06	3.93e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALB—melanoma	3.97e-06	3.88e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—melanoma	3.86e-06	3.77e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CB—melanoma	3.75e-06	3.67e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—melanoma	3.72e-06	3.64e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTEN—melanoma	3.7e-06	3.62e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HRAS—melanoma	3.57e-06	3.49e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CB—melanoma	3.51e-06	3.43e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—melanoma	3.48e-06	3.4e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—melanoma	3.41e-06	3.34e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AKT1—melanoma	3.32e-06	3.25e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTEN—melanoma	3.24e-06	3.17e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—melanoma	3.23e-06	3.16e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT1—melanoma	3.15e-06	3.08e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTEN—melanoma	3.03e-06	2.96e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AKT1—melanoma	2.64e-06	2.58e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—melanoma	2.61e-06	2.55e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—melanoma	2.29e-06	2.24e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—melanoma	2.14e-06	2.09e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AKT1—melanoma	2.13e-06	2.09e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKT1—melanoma	1.87e-06	1.83e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKT1—melanoma	1.75e-06	1.71e-05	CbGpPWpGaD
